Dominic Bowers

MBChB, MRCA, DipPharmMed
Head of Rare Diseases & Advanced Therapeutics

Dominic is a highly experienced pharmaceutical physician whose experience spans clinical development, clinical program execution and governance from translational medicine through to peri-registration.

Dominic started his career with higher medical training as an anaesthetist, working within tertiary and secondary centre intensive care and anaesthetic units. Dominic’s drug development therapeutic area expertise is extensive, broad and quite unique. Broadly, his experience includes the development of small molecules, biologics and Advanced Therapeutics (ATMPs).
Dominic joined industry at Quintiles (now IQVIA) and held a variety of different roles as a Medical Director in multiple therapeutic areas, including the leadership of executing the largest IBD pivotal global clinical trial with Vedolizumab that lead to its successful registration. He created & Chaired the Acute Care & Pain Therapeutic Centre of Excellence at Quintiles which consolidated the deep expertise in Quintiles within the field to ensure leading edge thought leadership, operational governance, best practice and bespoke strategic consultancy for clients.

Prior to joining tranScrip Dominic held the prestigious role of Head of Clinical at the Cell & Gene Therapy Catapult in the UK, where he led clinical execution of gene therapy, cell therapy & tissue engineering studies as well as broad clinical consultancy within immuno-oncology and rare diseases.